334 related articles for article (PubMed ID: 25562133)
1. Personalized medicine: CCO's vision, accomplishments and future plans.
Guo J; Kamel-Reid S; Rutherford M; Hart J; Melamed S; Pollett A
Healthc Q; 2015; 17 Spec No():41-3. PubMed ID: 25562133
[TBL] [Abstract][Full Text] [Related]
2. The opportunity and strategy for quality and health-system improvement now and in the future.
Sherar M; Maley O
Healthc Q; 2015; 17 Spec No():52-6. PubMed ID: 25562136
[TBL] [Abstract][Full Text] [Related]
3. Primary prevention - recent developments in policy and support.
Spayne M; Rabeneck L; Marrett L; Peter A
Healthc Q; 2015; 17 Spec No():10-5. PubMed ID: 25562128
[TBL] [Abstract][Full Text] [Related]
4. Improving the quality of lung cancer care in Ontario: the lung cancer disease pathway initiative.
Evans WK; Ung YC; Assouad N; Chyjek A; Sawka C
J Thorac Oncol; 2013 Jul; 8(7):876-82. PubMed ID: 23575416
[TBL] [Abstract][Full Text] [Related]
5. Creating a system for performance improvement in cancer care: Cancer Care Ontario's clinical governance framework.
Duvalko KM; Sherar M; Sawka C
Cancer Control; 2009 Oct; 16(4):293-302. PubMed ID: 19910915
[TBL] [Abstract][Full Text] [Related]
6. [Personalized medicine in oncology].
Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL
Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256
[TBL] [Abstract][Full Text] [Related]
7. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
Kotelnikova EA; Pyatnitskiy M; Paleeva A; Kremenetskaya O; Vinogradov D
Oncotarget; 2016 Aug; 7(32):52493-52516. PubMed ID: 27191992
[TBL] [Abstract][Full Text] [Related]
8. Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
Burstein HJ; Krilov L; Aragon-Ching JB; Baxter NN; Chiorean EG; Chow WA; De Groot JF; Devine SM; DuBois SG; El-Deiry WS; Epstein AS; Heymach J; Jones JA; Mayer DK; Miksad RA; Pennell NA; Sabel MS; Schilsky RL; Schuchter LM; Tung N; Winkfield KM; Wirth LJ; Dizon DS
J Clin Oncol; 2017 Apr; 35(12):1341-1367. PubMed ID: 28148207
[No Abstract] [Full Text] [Related]
9. Successes and challenges in population-based cancer screening.
Spayne M; Rabeneck L; Guerriero L
Healthc Q; 2015; 17 Spec No():16-22. PubMed ID: 25562129
[TBL] [Abstract][Full Text] [Related]
10. Toward individualized treatment in urologic oncology.
Rini BI
Urol Oncol; 2015 Apr; 33(4):170. PubMed ID: 25661236
[No Abstract] [Full Text] [Related]
11. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
12. Cancer molecular markers: A guide to cancer detection and management.
Nair M; Sandhu SS; Sharma AK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):39-55. PubMed ID: 29428478
[TBL] [Abstract][Full Text] [Related]
13. Genomic Medicine Takes the Stage, Again!
Tempero M
J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
[No Abstract] [Full Text] [Related]
14. Precision medicine in oncology: what is it exactly and where are we?
Le Tourneau C; Kamal M; Bièche I
Per Med; 2018 Sep; 15(5):351-353. PubMed ID: 30260312
[No Abstract] [Full Text] [Related]
15. The Future of Precision Medicine in Oncology.
Millner LM; Strotman LN
Clin Lab Med; 2016 Sep; 36(3):557-73. PubMed ID: 27514468
[TBL] [Abstract][Full Text] [Related]
16. Blueprint for cancer research: Critical gaps and opportunities.
Elmore LW; Greer SF; Daniels EC; Saxe CC; Melner MH; Krawiec GM; Cance WG; Phelps WC
CA Cancer J Clin; 2021 Mar; 71(2):107-139. PubMed ID: 33326126
[TBL] [Abstract][Full Text] [Related]
17. [Cancer: three eras of personalized medicine].
Jordan B
Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
[TBL] [Abstract][Full Text] [Related]
18. Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
Morgan G; Aftimos P; Awada A
Curr Opin Oncol; 2016 Sep; 28(5):441-6. PubMed ID: 27428363
[TBL] [Abstract][Full Text] [Related]
19. Imaging requirements for personalized medicine: the oncologists point of view.
Kruse V; Belle SV; Cocquyt V
Curr Pharm Des; 2014; 20(14):2234-49. PubMed ID: 24025098
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas13a system: a novel approach to precision oncology.
Zhang J; You Y
Cancer Biol Med; 2020 Feb; 17(1):6-8. PubMed ID: 32296572
[No Abstract] [Full Text] [Related]
[Next] [New Search]
